The rising incidence and prevalence of diabetes within the U. S. has resulted in a very synonymous increase of non-healing diabetic foot ulcers. Patients with these foot ulcers have flooded pressing care centers, medical care offices, podiatric services, patient wards, emergency rooms, and ultimately, wound care centers.
Such occurrences have resulted in a very boom of advance modalities to assist heal these ulcers and forestall amputations. These modalities embody bio engineered skin substitutes, living substance derived growth factors, negative pressure medical care, hyperbaric chemical element, advanced wound dressings, unhearable surgical procedure tools, “superbug” busting antibiotics, and vegetative cell medical care.
Bionova Life Sciences 